Aclaris Therapeutics Announces Participation in Upcoming Conferences
WAYNE, Pa. — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a promising clinical-stage biopharmaceutical company, is excited to announce its participation in two upcoming healthcare conferences throughout September. This involvement highlights the commitment of Aclaris to share its innovative developments with the healthcare community and potential investors.
Details of Conference Participation
On September 3, 2025, at 1:00 PM EDT, Aclaris' Chief Executive Officer, Dr. Neal Walker, along with the senior leadership team, will engage in a fireside chat during the esteemed Cantor Global Healthcare Conference. This event set in New York City provides a valuable platform for showcasing Aclaris’ strategic vision and progress in the biopharmaceutical space.
Insights at the H.C. Wainwright Conference
Following shortly, on September 9, 2025, at 9:00 AM EDT, Dr. Walker will present a corporate overview during the H.C. Wainwright 27th Annual Global Investment Conference. This event will allow Aclaris to delve deeper into their research and development strategies, and outline their goals surrounding novel product candidates aimed at treating immuno-inflammatory diseases.
Accessing Live Webcasts
For those interested in Aclaris’ presentations, live and archived webcasts of these events will be made available. Interested individuals can find the webcasts on the Aclaris website for a duration of at least 30 days following the events. This makes it accessible for a wider audience to stay informed regarding Aclaris Therapeutics’ advancements and initiatives.
About Aclaris Therapeutics, Inc.
Aclaris Therapeutics is dedicated to harnessing the potential of innovative treatments for patients suffering from immuno-inflammatory diseases. With a robust R&D pipeline, the company focuses on developing new solutions catering to patients who currently have limited treatment options. Their commitment is evident as they continuously strive to meet unmet medical needs through rigorous research and development.
Contact Information
If you have any inquiries or require further information about Aclaris Therapeutics, please reach out to:
Will Roberts
Senior Vice President
Corporate Communications and Investor Relations
(484) 329-2125
wroberts@aclaristx.com
Frequently Asked Questions
What is Aclaris Therapeutics known for?
Aclaris Therapeutics specializes in developing novel product candidates aimed at immuno-inflammatory diseases with insufficient treatment options.
Which conferences is Aclaris participating in?
Aclaris will participate in the Cantor Global Healthcare Conference and the H.C. Wainwright 27th Annual Global Investment Conference in September.
Who will represent Aclaris at these conferences?
Dr. Neal Walker, CEO of Aclaris, along with the senior leadership team, will represent the company during these key events.
How can I watch the Aclaris presentations?
You can access live and archived presentations on the Aclaris Therapeutics website for up to 30 days post-event.
Where can I find more information about Aclaris?
For detailed information, visit the Aclaris Therapeutics website at www.aclaristx.com.